News

Groundbreaking new prostate cancer test found to improve detection of aggressive forms - The simple test can be performed at ...
Experts have developed a new saliva test which analyses genetic variants in a man's DNA.The simple test, which can be performed at home and does not require a visit to a doctor, appeared to perform ...
For men at the highest risk of prostate cancer as determined by a polygenic risk score, the percentage found to have ...
A UK study found that using a polygenic risk score to identify men at highest genetic risk of prostate cancer significantly ...
MedPage Today on MSN8dOpinion
Precision Medicine for Prostate Cancer
Outranked only by skin cancer, prostate cancer is the second most common cancer in men in the U.S. Although one in every ...
Before a prostate biopsy is performed, various preliminary screening procedures are typically conducted. These include a ...
In a powerful talk with Mathew Knowles and Courtney Bugler, CEO of Zero Prostate Cancer, we highlight the urgent need for awareness among Black men at risk.
Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease who are eligible to receive the drug.
"It’s crucial that patients and their families know about this new option," said Dr. William Russell, an oncology radiologist ...
A new, AI-powered test can detect the molecular "fingerprints" of cancer in a patient's blood using flashes of infrared light ...
Dr. Ajaz Khan is the chief of medical oncology at City of Hope Chicago. He oversees the Illinois hospital’s staff of cancer ...
The MHRA has approved trofolastat to identify how far high-risk prostate cancer has spread before treatment, to detect ...